Clinical Trial Update: CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for a CD70-targeted CAR T therapy (CD70.CAR) in CD70-positive lymphoma, multiple myeloma, solid tumors, sarcoma, and kidney canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer
• Lymphoma
• Multiple Myeloma
• Sarcoma
• Solid Tumors

Drugs mentioned

• CD70.CAR

Snippet

Sponsor: Baylor College of Medicine | Conditions: Lymphoma, Myeloma | Phase 1 | Status: NOT_YET_RECRUITING